Pantothenic acid - a scoping review for Nordic Nutrition Recommendations 2023.
Level 5 - mechanism / opinion, no new human data
Scoping literature review without systematic quantitative synthesis of clinical trials
PubMed 38187802 · doi:10.29219/fnr.v67.10255
What was done
A scoping review was conducted to examine scientific literature published since 2012 on pantothenic acid (vitamin B5) intakes, biomarkers, and health associations to inform dietary reference values (DRVs) for the Nordic Nutrition Recommendations 2023 (NNR2023).
What was found
The abstract reports no numerical findings. It notes that pantothenic acid deficiency is rare, toxicity is negligible, intake data in Nordic countries are limited, and biomarker data from Nordic and Baltic populations are missing. No health concerns related to pantothenic acid intake were identified.
Why it matters
This review evaluates recent evidence for regional dietary guidelines, confirming an ongoing lack of population-specific intake and biomarker data needed to establish formal reference values.
Limits
The abstract provides no study counts, search databases, or quantitative details. Substantial gaps persist regarding regional biomarker and intake data in Nordic and Baltic populations.
Cited by
- supports Medical literature generally considers dietary vitamin B5 (pantothenic acid) deficiency non-existent or exceptionally rare because it is ubiquitous in all food sources.